A team of Orthopedic researchers at Jefferson Medical College have identified stem cells in the intervertebral discs of the human spine. The researchers said their findings suggest that such cells might someday be used to help repair degenerating discs and remedy lower back and neck pain.
The team led by Makarand Risbud, Ph.D., and Irving Shapiro, Ph.D., at Jefferson Medical College of Thomas Jefferson University in Philadelphia, have for the first time found stem cells in both degenerated adult human discs and in discs of animals.
Dr. Shapiro said that as the discs in the spine degenerate, cells are lost and the ability to produce water-binding molecules called proteoglycans is decreased. The water absorbs forces on the spine, essentially serving as shock absorbers. Losing proteoglycans can result in damage to the disc, and sometimes, pain.
The researcher's asked if it was possible to regenerate proteoglycans using adult stem cells. Federal regulations prevent them from using embryonic stem cells. Dr. Risbud built the study around the observation that while the tissue that he could isolate from the disc was no longer binding water, the tissue still might contain dormant stem cells. He thought that while these cells were no longer functioning to repair the damaged disc, under appropriate conditions, they could be activated.
To explore that possibility, he isolated cells from discarded disc tissue that still had the capacity to proliferate. He noted that under certain conditions, the cells could be encouraged to form bone. In other conditions, the cells would form cartilage or even fat. The tests proved that these cells were indeed dormant disc stem cells. "If we are able to stimulate the 'silent' cells in the patient, then it may be possible to repair the ravages of degenerative disc disease without undergoing invasive surgical procedures that may limit the motion of the spine," he said.
Dr. Risbud said, in earlier studies, the researchers found that local conditions in the disc can promote adult stem cells of the bone marrow to acquire characteristics of disc cells. Within the disc, the local conditions are unique in that the oxygen levels are low. These conditions cause the expression of many specialized molecules, including the water-binding proteoglycans.
Some of the researchers' current experiments focus on the use of adult stem cells to repair the degenerate intervertebral disc. Shapiro noted that other researchers have taken bone marrow stem cells and have made new bone, cartilage and fat tissue. "Our next step is to activate these disc stem cells and get them to repopulate the disc and make proteoglycans and restore the water-binding," he said.
The researchers theorize that because the stem cells exist in the degenerate disk, there may be molecules that are blocking stem cell activity. "Something is inhibiting the disc repair process," Dr. Shapiro said. Drs. Shapiro and Risbud agree that "new studies are needed to discover the nature of such inhibitory molecules" and to find ways to block their activities, promoting natural healing.
The study is published in November 1, 2007 issue in the journal Spine.